Adrienne Graves, Director at Akorn, holds 1.00K shares in Harrow Health (Ticker: HROW), holds 127.51K shares in Opus Genetics (Ticker: IRD), holds 50.00K shares in Ocular Therapeutix (Ticker: OCUL). Most recently, Adrienne Graves Bought ― shares of Harrow Health on May 19, 2026 for an estimated value of $31.07K.
Adrienne Graves latest transaction was an Informative Buy of $31.07K.
What was Adrienne Graves's most profitable transaction?
Adrienne Graves’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Adrienne Graves's role in Akorn?
Adrienne Graves's role in Akorn is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.